Dexamethasone Phosphate Bisulfate Adduct

Stability and compatibility of methotrexate and dexamethasone in 0.9​% sodium chloride for intrathecal injection
By Xu, Fan; Zeng, Su
From Pakistan Journal of Pharmaceutical Sciences (2020), 33(6), 2477-2481
 
Method development and validation for simultaneous estimation of ofloxacin and dexamethasone sodium phosphate by RP-​HPLC
By Renukadevi, G. N.; Lakshmi, M. Sri; Prathyusha, V.; Sharmila, S. K.; Kumari, K. Shantha
From World Journal of Pharmaceutical Research (2014), 3(Suppl.5), 369-381
 
Simultaneous estimation of moxifloxacin hydrochloride and dexamethasone sodium phosphate in bulk and in ophthalmic solution by RP-​HPLC
By Dhumal, D. M.; Shirkhedkar, A. A.; Nerkar, P. P.; Surana, S. J.
From Journal of the Chilean Chemical Society (2012), 57(4), 1344-1347

 
 

Dexamethasone Phosphate Bisulfate Adduct is chemically (8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-17-(2-(phosphonooxy)acetyl)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-1-sulfonic acid. Dexamethasone Phosphate Bisulfate Adduct is supplied with detailed characterization data compliant with regulatory guideline. Dexamethasone Phosphate Bisulfate Adduct can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dexamethasone sodium phosphate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.